This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsDeciphera PharmaceuticalsDeciphera Pharmaceuticals Funding Rounds, Valuation & Investors
Deciphera Pharmaceuticals company logo
Deciphera Pharmaceuticals
Enabled by our proprietary kinase switch control inhibitor platform, we have built a diver201-500 Employees
  • 4.5
    Work / Life Balance
    Employees rate Deciphera Pharmaceuticals 4.5/5 on Glassdoor for work / life balance
View 4 jobs

Deciphera Pharmaceuticals Funding

$127M
33 rounds
Deciphera Pharmaceuticals is active in the following markets / industries: medical, pharmaceuticals and therapeutics. The company has secured funding across 3 rounds, totaling in an amount of $127M. Their most recent funding was raised on June 1, 2017.

Funding Rounds

C
$52000000
Series CJun 2017
Avatar for Viking Global Investors
B
Undisclosed amount
Series BJan 2016$0 valuationRead press
Avatar for New Leaf Venture Partners
Avatar for SV Life Sciences
B
$75000000
Series BSep 2015$0 valuationRead press
Avatar for New Leaf Venture Partners

Investors of Deciphera Pharmaceuticals

Viking Global Investors
VC Firm • Stamford
Avatar for Viking Global Investors
Global investment firm managing capital across public equity, private equity, and credit strategies
Rounds
C
New Leaf Venture Partners
VC Firm • New York City
Avatar for New Leaf Venture Partners
Rounds
B
B
SV Life Sciences
VC Firm • Boston
Avatar for SV Life Sciences
Rounds
B
Back to Culture and benefits
Onwards to Jobs